摘要 ： 2025年9月11日，中国分析测试协会毒物分析分会成立，推动跨学科协作与技术创新，服务国家安全与公共健康。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 仪器信息网讯 2025年9月11日，在第二十一届北京分析测试学术报告会暨展览会（BCEIA 2025）召开期间，中国分析测试协会毒物分析分 会成立暨化学毒物分析前沿与交叉论坛正式召开，100余位代表出席。 毒物分析学作为融合分析科学、化学、医学等多学科的应用基础研究学科，对毒物分析方法、技术和检测试剂、装置研发及应用等前沿的探索 对防范化解复杂、多样、危害人类健康生存的毒物风险具有关键意义。这些探索不仅支撑临床毒检、司法鉴定、环境与食药品安全等领域的精 准化应用，更直接服务于国防与公共安全保障，为守护国家和人民健康安全提供科学支撑，是应对复杂安全挑战、筑牢社会安全防线的重要科 技保障。 中国分析测试协会毒物分析分会（以下简称分会）的成立旨在构建跨学科、应用领域的沟通协作平台，促进毒物分析领域的学术交流、技术协 同与创新应用，为我国分析测试协会事业的发展注入新动力。 本次成立大会 ...

Core Viewpoint - The "Research MDT" initiative at Jining First People's Hospital aims to enhance the integration of basic and clinical research, addressing challenges in diagnosing and treating invasive fungal diseases through interdisciplinary collaboration [1][3]. Group 1: Objectives and Initiatives - The initiative seeks to establish a regular communication mechanism between basic research and clinical departments, breaking down disciplinary barriers to improve clinical research capabilities [1]. - The first "Research MDT" successfully brought together experts from various departments, focusing on rapid diagnosis and treatment of fungal diseases [1][3]. Group 2: Challenges and Solutions - The hospital faces significant challenges such as delayed diagnosis of invasive fungal diseases and rising drug resistance, necessitating a collaborative approach to research and clinical practice [3]. - The integration of basic research in medical mycology with clinical diagnostics and treatment practices is essential for overcoming these challenges [3]. Group 3: Collaborative Efforts - The event facilitated discussions on critical issues like drug-resistant fungal infections and innovative treatment methods, fostering a collaborative environment between clinical and research personnel [3][4]. - The "Research MDT" serves as a platform for clinical practitioners to gain insights into laboratory breakthroughs while researchers understand the pressing clinical challenges [4]. Group 4: Future Directions - The hospital plans to continue nurturing this innovative environment, ensuring that laboratory findings are effectively translated into clinical applications to strengthen patient care [4].